Novo’s Victoza gets partial OK from NICE for diabetes – Pharma Times


TopNews New Zealand
Novo’s Victoza gets partial OK from NICE for diabetes
Pharma Times
Novo Nordisk’s Victoza is being recommended by the National Institute for Health and Clinical Excellence as a treatment for diabetes on the National Health
NICE draft appraisal approves liraglutide for type 2 diabetes Pulse
UK Body Gives Limited Backing To Novo Nordisk Diabetes Drug Wall Street Journal
NHS Diabetes Care Continues to Improve Article Ant (press release)
eMaxHealth  - TopNews New Zealand  - BusinessWeek
all 17 news articles »

Tags: , , , , , , ,

Leave a Reply